000			02089 a2200601 4500
005			20250518011230.0
264		0	_c20200413
008			202004s 0 0 eng d
022			_a1538-7836
024	7		_a10.1111/jth.14342 _2doi
040			_aNLM _beng _cNLM
100	1		_aLewis, C S
245	0	0	_amTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors. _h[electronic resource]
260			_bJournal of thrombosis and haemostasis : JTH _c01 2019
300			_a169-182 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aHumans
650	0	4	_aMechanistic Target of Rapamycin Complex 1 _xmetabolism
650	0	4	_aMechanistic Target of Rapamycin Complex 2 _xmetabolism
650	0	4	_aMice, Nude
650	0	4	_aNeuroendocrine Tumors _xdrug therapy
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aSignal Transduction
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aThromboplastin _xgenetics
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aElnakat Thomas, H
700	1		_aOrr-Asman, M A
700	1		_aGreen, L C
700	1		_aBoody, R E
700	1		_aMatiash, K
700	1		_aKarve, A
700	1		_aHisada, Y M
700	1		_aDavis, H W
700	1		_aQi, X
700	1		_aMercer, C A
700	1		_aLucas, F V
700	1		_aAronow, B J
700	1		_aMackman, N
700	1		_aVersteeg, H H
700	1		_aBogdanov, V Y
773	0		_tJournal of thrombosis and haemostasis : JTH _gvol. 17 _gno. 1 _gp. 169-182
856	4	0	_uhttps://doi.org/10.1111/jth.14342 _zAvailable from publisher's website
999			_c29087223 _d29087223